NCS Inaugurates Theranostics Center

Filed under "Press Releases"
More articles »


Theranostics is a new field of medicine which combines specific targeted therapy based upon a specific targeted diagnostic test. With a key focus on patient centered care, theranostics provides a transition from conventional medicine to contemporary personalized and precision medicine.

The diagnostic component of theranostics determines and defines the type and extent of disease This information allows decisions to be made on timing, quantity, type of drugs, and choice of treatment options, as well as helping to evaluate a patient’s response to treatment.

The development of the companion therapeutic component focuses on individualizing treatment by targeting therapy to the individual’s specific disease. Because the therapeutic agent is specifically targeted to sites of disease (with significantly reduced drug exposure to normal tissue), higher doses of the therapeutic agent may be safely administered.

Click on the link below to learn more information about the treatment and how you can benefit from it.

https://www.carcinoid.org/2018/07/26/peptide-receptor-radionuclide-therapy-prrt-updates-and-locations/